封面
市场调查报告书
商品编码
1407380

血糖试纸市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测,按类型、最终用户区域和竞争细分

Blood Glucose Test Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By End-User Region and Competition

出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年,全球血糖试纸市场价值为 105.3 亿美元,预计在预测期内将强劲增长,到 2028 年复合CAGR为4.40%。在以下因素的推动下,全球血糖试纸市场见证了显着增长和演变:全球糖尿病盛行率不断上升。这些试纸在监测和管理血糖水平方面发挥着至关重要的作用,使糖尿病患者能够对自己的健康做出明智的决定。市场的特点是技术的不断进步,导致更准确和用户友好的测试条的开发。人们越来越认识到定期血糖监测的重要性,加上糖尿病人口的不断增长,刺激了对这些试纸条的需求。

导致全球血糖试纸市场扩张的关键因素之一是久坐的生活方式、不健康的饮食习惯和人口迅速老化导致的糖尿病发病率不断上升。随着糖尿病成为全球健康问题,对高效、可靠的血糖监测设备(包括试纸)的需求持续成长。此外,由于非处方试纸的便利性和可近性,市场已经见证了向家庭血糖监测的转变。这一趋势不仅使糖尿病患者能够掌控自己的健康,而且还促进了市场的整体成长。

技术进步在提高血糖试纸性能方面发挥了关键作用。持续创新促进了智慧互联设备的发展,实现了与智慧型手机和其他数位平台的无缝集成,以实现即时监控和资料管理。这些发展不仅改善了使用者体验,也为医疗保健专业人员提供了有关患者血糖模式的宝贵见解,从而实现个人化治疗计划。然而,市场并非没有挑战,因为报销问题和某些地区试纸的高成本等问题可能会阻碍广泛采用。

市场概况
预测期 2024-2028
2022 年市场规模 105.3亿美元
2028 年市场规模 135.1亿美元
2023-2028 年CAGR 4.40%
成长最快的细分市场 亚太地区
最大的市场 北美洲

主要市场驱动因素

目录

第 1 章:产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章:研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章:执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章:全球血糖试纸市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依类型(厚膜电化学膜、薄膜电化学膜、光带)
    • 按最终使用者(医院、门诊手术中心、其他最终使用者)
    • 按地区
    • 按公司划分 (2022)
  • 市场地图
    • 按类型
    • 按最终用户
    • 按地区

第 5 章:亚太地区血糖试纸市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按最终用户
    • 按国家/地区
  • 亚太地区:国家分析
    • 中国血糖试纸
    • 印度血糖试纸
    • 澳洲血糖试纸
    • 日本血糖试纸
    • 韩国血糖试纸

第 6 章:欧洲血糖试纸市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按最终用户
    • 按国家/地区
  • 欧洲:国家分析
    • 法国
    • 德国
    • 西班牙
    • 义大利
    • 英国

第 7 章:北美血糖试纸市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按最终用户
    • 按国家/地区
  • 北美:国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 8 章:南美洲血糖试纸市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按最终用户
    • 按国家/地区
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 9 章:中东和非洲血糖试纸市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按最终用户
    • 按国家/地区
  • MEA:国家分析
    • 南非血糖试纸
    • 沙乌地阿拉伯血糖试纸
    • 阿联酋血糖试纸
    • 埃及血糖试纸

第 10 章:市场动态

  • 司机
  • 挑战

第 11 章:市场趋势与发展

  • 最近的发展
  • 产品发布
  • 併购

第 12 章:全球血糖试纸市场:SWOT 分析

第 13 章:波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第14章:竞争格局

  • 雅培实验室公司
    • Company Snapshot
    • Products & Services
    • Current Capacity Analysis
    • Financials (In case of listed)
    • Recent Developments
    • SWOT Analysis
  • F.霍夫曼-拉罗氏有限公司
  • LifeScan IP 控股有限责任公司
  • i-SENS 公司
  • Ascensia 糖尿病照护控股公司
  • AgaMatrix,Elektronika Sales Pvt Ltd.
  • 通用生物感测器
  • 台元科技股份有限公司
  • B.Braun Melsungen AG(德国)
  • 雅培实验室公司

第 15 章:策略建议

第 16 章:关于我们与免责声明

简介目录
Product Code: 20211

Global Blood Glucose Test Strips Market has valued at USD 10.53 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 4.40% through 2028. The Global Blood Glucose Test Strips Market has witnessed significant growth and evolution, driven by the rising prevalence of diabetes worldwide. These test strips play a crucial role in monitoring and managing blood glucose levels, enabling individuals with diabetes to make informed decisions about their health. The market is characterized by the continuous advancements in technology, leading to the development of more accurate and user-friendly test strips. The increasing awareness about the importance of regular blood glucose monitoring, coupled with the growing diabetic population, has fueled the demand for these strips.

One of the key factors contributing to the expansion of the global blood glucose test strips market is the increasing incidence of diabetes, driven by sedentary lifestyles, unhealthy dietary habits, and a rapidly aging population. As diabetes becomes a global health concern, the demand for efficient and reliable blood glucose monitoring devices, including test strips, continues to rise. Moreover, the market has witnessed a shift toward home-based glucose monitoring, facilitated by the convenience and accessibility of over-the-counter test strips. This trend has not only empowered individuals with diabetes to take charge of their health but has also contributed to the market's overall growth.

Technological advancements have played a pivotal role in enhancing the performance of blood glucose test strips. Continuous innovation has led to the development of smart and connected devices, enabling seamless integration with smartphones and other digital platforms for real-time monitoring and data management. These developments not only improve user experience but also provide healthcare professionals with valuable insights into patients' glucose patterns, enabling personalized treatment plans. However, the market is not without challenges, as issues such as reimbursement concerns and the high cost of test strips in certain regions may hinder widespread adoption.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 10.53 Billion
Market Size 2028USD 13.51 Billion
CAGR 2023-20284.40%
Fastest Growing SegmentAsia Pacific
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Diabetes

The rising incidence of diabetes globally is a major driving force behind the burgeoning growth of the Global Blood Glucose Test Strips Market. Diabetes, characterized by elevated levels of blood glucose, has reached epidemic proportions, impacting millions of individuals worldwide. According to the International Diabetes Federation (IDF), approximately 537 million people were living with diabetes in 2021, and this number is expected to rise to 643 million by 2030. This escalating prevalence has created an urgent need for effective tools to monitor and manage blood glucose levels, leading to an increased demand for blood glucose test strips.

The surge in diabetes cases is attributed to various factors, including sedentary lifestyles, unhealthy dietary habits, genetic predisposition, and an aging population. Modern lifestyles, marked by reduced physical activity and the consumption of processed foods, contribute to the development of obesity and insulin resistance, both of which are key risk factors for type 2 diabetes. Additionally, an aging global population adds to the prevalence of diabetes, as the risk of developing the condition increases with age.

As the diabetic population continues to grow, the importance of regular blood glucose monitoring becomes paramount in managing the disease effectively. Blood glucose test strips play a crucial role in this regard, allowing individuals with diabetes to measure their blood sugar levels at home or in clinical settings. This real-time monitoring is essential for making informed decisions about lifestyle choices, medication management, and overall diabetes care. The increasing awareness among healthcare professionals and patients about the significance of continuous glucose monitoring has contributed significantly to the uptake of blood glucose test strips.

Furthermore, the rising incidence of diabetes has spurred innovations in blood glucose monitoring technology. Manufacturers are investing in research and development to enhance the accuracy, efficiency, and user-friendliness of test strips. Technological advancements, such as the integration of smart features and connectivity options, provide users with a more seamless and convenient experience. These innovations not only meet the growing demand for reliable glucose monitoring tools but also contribute to the overall expansion of the blood glucose test strips market.

Growing Awareness and Focus on Diabetes Management

The Global Blood Glucose Test Strips Market is experiencing a substantial boost due to the growing awareness and increased focus on diabetes management. In recent years, there has been a significant paradigm shift towards proactive healthcare, with a particular emphasis on chronic disease management, and diabetes has emerged as a key target for intervention. Governments, healthcare organizations, and advocacy groups worldwide are increasingly investing in awareness campaigns to educate the public about the risks associated with diabetes and the importance of effective management.

This heightened awareness has translated into a more informed and empowered patient population, leading to an increased demand for tools that facilitate active participation in diabetes management. Blood glucose test strips play a central role in this scenario, allowing individuals with diabetes to monitor their blood sugar levels regularly. The awareness campaigns emphasize the benefits of regular monitoring, underscoring how it enables individuals to make timely adjustments to their lifestyle, medication, and dietary choices. This proactive approach aligns with the broader trend in healthcare towards preventive measures and personalized medicine.

Healthcare professionals also play a pivotal role in driving awareness and fostering a focus on diabetes management. With an increasing number of patients diagnosed with diabetes, there is a growing realization among healthcare providers about the critical role of regular blood glucose monitoring in achieving optimal outcomes for patients. As a result, there is a stronger emphasis on educating patients about the proper use of blood glucose test strips and integrating these tools into comprehensive diabetes management plans. This collaboration between healthcare professionals and patients contributes significantly to the market growth by fostering a culture of self-care and proactive disease management.

Moreover, the advent of technological advancements in blood glucose monitoring has further amplified the focus on diabetes management. The integration of smart features into blood glucose test strips, such as connectivity with mobile devices and data-sharing capabilities, aligns with the trend towards digital health solutions. These innovations not only make monitoring more convenient for individuals with diabetes but also enable healthcare professionals to access real-time data for more informed decision-making. The synergy between technological advancements, growing awareness, and a focus on diabetes management is propelling the global blood glucose test strips market to new heights.

Technological Advancements in Glucose Monitoring Devices

Technological advancements in glucose monitoring devices are playing a pivotal role in boosting the Global Blood Glucose Test Strips Market. Over the years, there has been a remarkable evolution in the field of diabetes management, with a focus on developing more sophisticated and user-friendly monitoring devices. The integration of advanced technology into glucose monitoring devices has not only enhanced the accuracy of blood glucose measurements but has also significantly improved the overall user experience.

One of the key technological advancements is the development of devices that require smaller blood samples. This innovation addresses a common concern among individuals with diabetes, making the testing process less invasive and more comfortable. Smaller sample requirements also contribute to the convenience of testing, encouraging users to monitor their blood glucose levels regularly.

Modern glucose monitoring devices deliver faster results, providing users with real-time information about their blood glucose levels. This rapid turnaround time is critical for individuals with diabetes, enabling them to make immediate adjustments to their treatment plans or lifestyle choices based on the latest readings.

The integration of smart technology into glucose monitoring devices represents a revolutionary shift in the industry. Many devices now come equipped with Bluetooth connectivity, allowing seamless integration with smartphones and other digital platforms. Users can easily transfer their glucose readings to mobile applications for comprehensive data tracking and analysis. This connectivity not only enhances the user experience but also facilitates remote monitoring by healthcare professionals, enabling timely interventions and personalized treatment plans.

Continuous glucose monitoring (CGM) systems are another technological advancement that has gained prominence in the diabetes management landscape. These systems provide real-time glucose readings throughout the day, offering a more comprehensive view of blood glucose patterns. While CGM systems themselves may not use traditional test strips, they contribute to the overall ecosystem of glucose monitoring, influencing user preferences and expectations for accuracy and convenience.

Key Market Challenges

Cost Of Blood Glucose Test Strips

The overall cost of blood glucose test strips stands out as a formidable obstacle hindering the seamless growth of the Global Blood Glucose Test Strips Market. While these strips are indispensable for individuals managing diabetes, their affordability remains a critical concern, impacting accessibility for a significant portion of the global population.

One of the primary factors contributing to the high cost of blood glucose test strips is the intricate technology embedded in their design. Continuous innovation in the field has led to the development of more accurate and user-friendly strips, but these advancements often come at a price. The incorporation of cutting-edge features, such as smaller sample requirements, faster results, and connectivity options, necessitates sophisticated manufacturing processes, materials, and quality control measures, all of which contribute to the overall production cost.

The economic burden of diabetes management is further exacerbated by the need for regular testing. Individuals with diabetes often require multiple tests per day to effectively monitor and manage their blood glucose levels. This frequency of use amplifies the financial strain, especially for those without comprehensive insurance coverage or access to government reimbursement programs. As a result, cost considerations become a significant barrier, potentially leading to reduced compliance with recommended testing frequencies.

Standardization And Regulatory Compliance

Standardization and regulatory compliance emerge as formidable challenges hindering the smooth expansion of the Global Blood Glucose Test Strips Market. The market's growth is intricately tied to the ability to provide reliable, accurate, and consistent blood glucose readings, necessitating adherence to global standards and regulatory frameworks. However, achieving harmonization in testing protocols and regulatory requirements across different regions proves to be a complex task.

One of the primary challenges associated with standardization is the divergence in testing methodologies. Various regions and countries may adopt different standards for evaluating the accuracy and performance of blood glucose test strips. These disparities can lead to confusion among manufacturers, healthcare professionals, and consumers alike, impacting the reliability and consistency of results. Achieving global alignment on standardized testing methodologies is essential for fostering confidence in the accuracy of blood glucose readings and promoting the interoperability of testing systems.

The regulatory landscape further complicates the scenario, with different countries imposing distinct requirements for the approval and commercialization of blood glucose test strips. Regulatory compliance becomes a significant hurdle for manufacturers looking to introduce their products in multiple markets. Navigating the intricate web of regulatory frameworks demands significant resources and time, potentially slowing down the introduction of innovative and improved test strips to consumers.

Key Market Trends

Integration Of Smart Technology into Monitoring Devices

The integration of smart technology into monitoring devices is playing a pivotal role in boosting the Global Blood Glucose Test Strips Market. Modern blood glucose monitoring devices have evolved beyond traditional standalone meters, incorporating intelligent features that leverage connectivity with smartphones and other digital platforms. This integration has transformed the way individuals manage their diabetes, enhancing the overall user experience and providing healthcare professionals with valuable insights.

One of the key advantages of smart technology integration is the seamless transfer of blood glucose readings to mobile applications. Users can easily sync their monitoring devices with smartphones, allowing for real-time data tracking and analysis. This connectivity facilitates comprehensive and immediate access to glucose trends and patterns, empowering individuals to make informed decisions about their diabetes management. The ability to share this data with healthcare professionals also enables remote monitoring, ensuring timely interventions and personalized treatment plans.

The integration of smart features not only enhances the functionality of blood glucose monitoring devices but also contributes to increased user engagement. Smartphone connectivity enables users to receive alerts, reminders, and insights based on their glucose levels, fostering a proactive approach to diabetes management. The interactive and user-friendly interfaces of mobile applications make it easier for individuals to interpret their data, track trends over time, and collaborate with healthcare providers for more effective care.

Moreover, the integration of smart technology into monitoring devices aligns with the broader trend of digital health and the Internet of Things (IoT). This connectivity enables the creation of a connected ecosystem where various health data points can be monitored and analyzed in real-time. The holistic view provided by smart devices enhances the understanding of the relationship between lifestyle factors, medication adherence, and blood glucose levels, contributing to a more comprehensive and personalized approach to diabetes care.

Home-Based Glucose Monitoring

The Global Blood Glucose Test Strips Market is experiencing a substantial boost, thanks to the growing trend of home-based glucose monitoring. This shift in diabetes management has significantly contributed to the increasing demand for blood glucose test strips. Home-based monitoring offers individuals with diabetes the convenience of regularly tracking their blood sugar levels without the need for frequent visits to healthcare facilities. This trend is propelled by the availability of user-friendly blood glucose test strips that empower patients to perform tests in the comfort of their homes.

The convenience of home-based glucose monitoring has reshaped the dynamics of diabetes care. Individuals can easily integrate blood glucose testing into their daily routines, fostering a proactive and consistent approach to managing their condition. The ease of use of modern blood glucose test strips has eliminated many barriers to regular monitoring, encouraging individuals to adhere to recommended testing frequencies. This increased compliance not only supports better diabetes management but also fuels the demand for blood glucose test strips, making them a crucial component of home-based monitoring kits.

Moreover, home-based glucose monitoring aligns with the broader trend of patient-centered care and self-management. Empowering individuals to take an active role in their health is a key goal in modern healthcare, and home-based monitoring achieves this by providing a sense of control and autonomy to those with diabetes. The immediate feedback from blood glucose test strips enables users to make timely adjustments to their treatment plans, lifestyle, and dietary choices, leading to more personalized and effective diabetes management.

The market for blood glucose test strips benefits from the increasing awareness among healthcare professionals and patients about the advantages of home-based monitoring. Healthcare providers are recognizing the value of regular blood glucose monitoring in achieving optimal outcomes for patients. The integration of home-based monitoring into diabetes management plans underscores the importance of blood glucose test strips as essential tools for both patients and healthcare professionals.

Segmental Insights

Type Insights

Based on the Type, Thin Film Electrochemical Films emerged as the dominant segment in the global market for Global Blood Glucose Test Strips in 2022. Thin Film Electrochemical Films are the most widely utilized type in the Global Blood Glucose Test Strips Market, creating high demand. This preference can be attributed to several factors that make thin film technology advantageous for blood glucose monitoring. Thin Film Electrochemical Films offer enhanced accuracy and precision in blood glucose measurements. The thin layers used in these films allow for more rapid and consistent electrochemical reactions, leading to reliable and real-time glucose readings. This accuracy is crucial for individuals with diabetes to make informed decisions about their treatment and lifestyle adjustments.

End-User Insights

Based on the End-User, Hospitals emerged as the dominant segment in the global market for Global Blood Glucose Test Strips Market in 2022. hospitals are primary healthcare institutions that cater to a diverse patient population, including those with diabetes. The high footfall of patients in hospitals, coupled with the prevalence of diabetes worldwide, results in a substantial demand for blood glucose test strips. Hospitals serve as hubs for diagnostics, treatment, and monitoring of various medical conditions, making them a key consumer of blood glucose monitoring products. hospitals are equipped with comprehensive healthcare infrastructure, including laboratories and specialized departments, which facilitate the efficient use of blood glucose test strips. The presence of trained healthcare professionals, such as nurses and laboratory technicians, ensures proper usage of the test strips and accurate interpretation of results. The centralized nature of hospital settings allows for streamlined and coordinated diabetes management, with blood glucose monitoring being an integral part of routine care.

Regional Insights

The North American region has been at the forefront of technological innovation in healthcare, including diabetes management. The development of advanced glucose monitoring devices, incorporating cutting-edge technologies, has significantly contributed to the dominance of North America in the blood glucose test strips market. Continuous glucose monitoring systems (CGMS) and smart glucose meters with enhanced features have become increasingly prevalent in the region, fostering a culture of innovation and driving market growth. North America, particularly the United States, has stringent regulatory standards in place for medical devices, ensuring the safety and efficacy of healthcare products. Compliance with these standards is crucial for market entry and sustained growth.

Key Market Players

Abbott Laboratories Inc

F. Hoffmann-La Roche Ltd

LifeScan IP Holdings, LLC

i-SENS, Inc.

Ascensia Diabetes Care Holdings AG

AgaMatrix, Elektronika Sales Pvt Ltd.

Universal Biosensors

TaiDoc Technology Corporation

B. Braun Melsungen AG

Report Scope:

In this report, the Global Blood Glucose Test Strips Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Blood Glucose Test Strips Market, By Type:

  • Thick Film Electrochemical Films
  • Thin Film Electrochemical Films
  • Optical Strips

Global Blood Glucose Test Strips Market, By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users

Global Blood Glucose Test Strips Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Blood Glucose Test Strips Market.

Available Customizations:

  • Global Blood Glucose Test Strips Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Blood Glucose Test Strips Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type (Thick Film Electrochemical Films, Thin Film Electrochemical Films, Optical Strips)
    • 4.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users)
    • 4.2.3. By Region
    • 4.2.4. By Company (2022)
  • 4.3. Market Map
    • 4.3.1. By Type
    • 4.3.2. By End-User
    • 4.3.3. By Region

5. Asia Pacific Blood Glucose Test Strips Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By End-User
    • 5.2.3. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Blood Glucose Test Strips Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Type
        • 5.3.1.2.2. By End-User
    • 5.3.2. India Blood Glucose Test Strips Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Type
        • 5.3.2.2.2. By End-User
    • 5.3.3. Australia Blood Glucose Test Strips Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Type
        • 5.3.3.2.2. By End-User
    • 5.3.4. Japan Blood Glucose Test Strips Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Type
        • 5.3.4.2.2. By End-User
    • 5.3.5. South Korea Blood Glucose Test Strips Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Type
        • 5.3.5.2.2. By End-User

6. Europe Blood Glucose Test Strips Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Blood Glucose Test Strips Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End-User
    • 6.3.2. Germany Blood Glucose Test Strips Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End-User
    • 6.3.3. Spain Blood Glucose Test Strips Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End-User
    • 6.3.4. Italy Blood Glucose Test Strips Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By End-User
    • 6.3.5. United Kingdom Blood Glucose Test Strips Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By End-User

7. North America Blood Glucose Test Strips Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Blood Glucose Test Strips Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End-User
    • 7.3.2. Mexico Blood Glucose Test Strips Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End-User
    • 7.3.3. Canada Blood Glucose Test Strips Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End-User

8. South America Blood Glucose Test Strips Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Blood Glucose Test Strips Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End-User
    • 8.3.2. Argentina Blood Glucose Test Strips Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End-User
    • 8.3.3. Colombia Blood Glucose Test Strips Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End-User

9. Middle East and Africa Blood Glucose Test Strips Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Blood Glucose Test Strips Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End-User
    • 9.3.2. Saudi Arabia Blood Glucose Test Strips Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End-User
    • 9.3.3. UAE Blood Glucose Test Strips Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End-User
    • 9.3.4. Egypt Blood Glucose Test Strips Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By End-User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Blood Glucose Test Strips Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Abbott Laboratories Inc.
    • 14.1.1. Company Snapshot
    • 14.1.2. Products & Services
    • 14.1.3. Current Capacity Analysis
    • 14.1.4. Financials (In case of listed)
    • 14.1.5. Recent Developments
    • 14.1.6. SWOT Analysis
  • 14.2. F. Hoffmann-La Roche Ltd
  • 14.3. LifeScan IP Holdings, LLC
  • 14.4. i-SENS, Inc.
  • 14.5. Ascensia Diabetes Care Holdings AG
  • 14.6. AgaMatrix, Elektronika Sales Pvt Ltd.
  • 14.7. Universal Biosensors
  • 14.8. TaiDoc Technology Corporation
  • 14.9. B. Braun Melsungen AG (Germany)
  • 14.10. Abbott Laboratories Inc

15. Strategic Recommendations

16. About Us & Disclaimer